Statistics for Pharma Mar SA (id:4703 PHM)
Valuation metrics
Market cap
1.37B
Enterprise value
1.28B
Trailing P/E (ttm)
1.98K
Forward P/E
21.41
PEG ratio
21.41
Price/Sales (ttm)
8.22
Price/Book (mrq)
7.61
Enterprise Value/Revenue
7.65
Enterprise Value/EBITDA
-2,677.40
Overview
Shares outstanding
17.38M
Float
13.63M
Shares short
% Held by insiders
3.00%
% Held by institutions
5.00%
Average volume (10 days)
74.06K
Average volume (90 days)
Price summary
52-Week low
26.16
52-Week high
86.40
52-Week change
45.81%
Beta
5.00
50-Day moving average
68.71
200-Day moving average
43.61
Dividends and splits
Forward annual dividend rate
2.60
Forward annual dividend yield
5.00
Trailing annual dividend rate
3.00%
Trailing annual dividend yield
5.00
5-Year annual dividend yield
Payout ratio
15.81
Dividend date
Ex-dividend date
June 12, 2024
Last split factor
2:1
Last split date
July 22, 2020
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
3.00%
Operating margin
12.00%
Operational effectiveness
Return on assets
3.00%
Return on equity
3.00%
Income statement
Revenue (ttm)
9.52
Revenue per share (ttm)
9.52
Quarterly revenue growth (yoy)
1.57
Gross profit (ttm)
148.54M
EBITDA
4.08M
Net income to common (ttm)
622.00K
Diluted EPS (ttm)
5.00
Quarterly earnings growth (yoy)
156.70%
Balance sheet
Total cash (mrq)
144.39M
Total cash per share (mrq)
8.23
Total debt (mrq)
53.48M
Total Debt/Equity (mrq)
29.36
Current ratio (mrq)
266.10%
Book value per share (mrq)
10.39
Cash flow
Cash flow statement
1.65M
Levered free cash flow (LFCF)
-17,049,376.00